Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)
This study has been completed.
Sponsor:
CSL Limited
Information provided by (Responsible Party):
CSL Limited
ClinicalTrials.gov Identifier:
NCT00405184
First received: November 27, 2006
Last updated: June 5, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2008 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |